Acasti Pharma eyeing FDA meeting as it continues to advance heart disease candidate CaPre
ShareRoot plans Opyl transformation under leadership of Michelle Gallaher and Julian Chick
Admedus makes "transformational" sale of CardioCel and VascuCel for $36.2 million
Only registered members can use this feature.
© Proactive Investors 2019.
Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority. Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.